Chelsea Counsel CO Amgen Inc Transaction History

Chelsea Counsel CO

$173 Million
Q1 2024

A detailed history of Chelsea Counsel CO transactions in Amgen Inc stock. As of the latest transaction made, Chelsea Counsel CO holds 13,627 shares of AMGN stock, worth $4.26 Million. This represents 2.24% of its overall portfolio holdings.

Number of Shares

13,627

Previous 13,742 0.84%

Holding current value

$4.26 Million

Previous $3.96 Million 2.1%

% of portfolio

2.24%

Previous 2.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 14, 2024	SELL	$268.87 - $324.56 $30,920 - $37,324	-115 Reduced 0.84%	13,627 $3.87 Million
Q4 2023 Feb 21, 2024	SELL	$255.7 - $288.46 $179,757 - $202,787	-703 Reduced 4.87%	13,742 $3.96 Million
Q3 2023 Nov 22, 2023	SELL	$218.65 - $271.46 $33,890 - $42,076	-155 Reduced 1.06%	14,445 $3.88 Million
Q2 2023 Nov 22, 2023	BUY	$214.27 - $253.37 $25,712 - $30,404	120 Added 0.83%	14,600 $3.24 Million
Q1 2023 May 19, 2023	SELL	$225.79 - $275.2 $28,223 - $34,400	-125 Reduced 0.86%	14,480 $3.5 Million

Q4 2022 Feb 23, 2023	SELL	$229.03 - $291.01 $136,959 - $174,023	-598 Reduced 3.93%	14,605 $3.84 Million
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $347,464 - $391,876	-1,548 Reduced 9.24%	15,203 $3.43 Million
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $61,138 - $68,036	-265 Reduced 1.56%	16,751 $4.08 Million
Q1 2022 May 24, 2022	SELL	$219.27 - $242.57 $86,611 - $95,815	-395 Reduced 2.27%	17,016 $4.12 Million
Q4 2021 May 23, 2022	SELL	$198.88 - $227.6 $120,521 - $137,925	-606 Reduced 3.36%	17,411 $3.92 Million
Q3 2021 Feb 10, 2022	SELL	$212.27 - $248.7 $52,006 - $60,931	-245 Reduced 1.34%	18,017 $3.83 Million
Q2 2021 Feb 10, 2022	BUY	$233.58 - $259.14 $170,980 - $189,690	732 Added 4.18%	18,262 $4.45 Million
Q1 2021 Feb 10, 2022	SELL	$221.91 - $258.6 $169,983 - $198,087	-766 Reduced 4.19%	17,530 $4.36 Million
Q4 2020 Mar 08, 2022	BUY	$216.38 - $257.67 $104,295 - $124,196	482 Added 2.71%	18,296 $4.21 Million
Q3 2020 May 06, 2022	SELL	$234.65 - $260.95 $290,966 - $323,578	-1,240 Reduced 6.51%	17,814 $4.53 Million
Q2 2020 May 06, 2022	BUY	$197.81 - $242.74 $20,572 - $25,244	104 Added 0.55%	19,054 $4.49 Million
Q1 2020 Jun 12, 2020	BUY	$182.24 - $241.7 $34,625 - $45,923	190 Added 1.01%	18,950 $3.84 Million
Q4 2019 Mar 23, 2020	SELL	$189.21 - $243.2 $186,371 - $239,552	-985 Reduced 4.99%	18,760 $4.52 Million
Q3 2019 Mar 27, 2020	BUY	$174.11 - $208.62 $284,495 - $340,885	1,634 Added 9.02%	19,745 $3.82 Million
Q3 2019 Mar 23, 2020	SELL	$174.11 - $208.62 $636,023 - $762,088	-3,653 Reduced 16.78%	18,111 $0
Q2 2019 Dec 09, 2019	SELL	$166.7 - $195.41 $33,340 - $39,082	-200 Reduced 0.91%	21,764 $4.01 Million
Q1 2019 Dec 09, 2019	SELL	$180.87 - $203.88 $83,019 - $93,580	-459 Reduced 2.05%	21,964 $4.17 Million
Q4 2018 Dec 09, 2019	BUY	$178.4 - $208.25 $10,704 - $12,495	60 Added 0.27%	22,423 $4.37 Million
Q3 2018 Dec 09, 2019	BUY	$185.29 - $208.89 $337,042 - $379,970	1,819 Added 8.85%	22,363 $4.64 Million
Q2 2018 Oct 03, 2018	SELL	$166.05 - $186.51 $318,317 - $357,539	-1,917 Reduced 8.53%	20,544 $3.79 Million
Q1 2018 Oct 03, 2018	BUY	$169.43 - $198.0 $11,860 - $13,860	70 Added 0.31%	22,461 $3.83 Million
Q4 2017 Jan 12, 2018	SELL	$168.79 - $188.59 $784,873 - $876,943	-4,650 Reduced 17.2%	22,391 $3.89 Million
Q3 2017 Jan 12, 2018	SELL	$167.29 - $191.0 $47,175 - $53,862	-282 Reduced 1.03%	27,041 $5.04 Million
Q2 2017 Jan 22, 2018	BUY	N/A	27,323	27,323 $4.71 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chelsea Counsel CO, based on Form 13F filings with the SEC.

News

Stay updated on Chelsea Counsel CO with notifications on news.

Account

Chelsea Counsel CO Amgen Inc Transaction History